Article
Systemic Therapies for Metastatic Pancreatic Neuroendocrine Tumors.
Current treatment options in oncology - 27 Nov 2019
Hauser Haley, Gerson Daniela Shveid, Reidy-Lagunes Diane, Raj Nitya
Abstract excerpt
OPINION STATEMENT: Over the years, there have been significant advances in systemic treatments for metastatic pancreatic neuroendocrine tumors (panNETs). Despite these advancements, uncertainty remains regarding how to best sequence available therapies. For well-differentiated and metastatic panNETs that are somatostatin receptor (SSTR) avid on functional imaging, first-line therapy typically consists of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
